Actively Recruiting
Efficacy of Light Therapy in Treatment of Chronic Cluster Headache
Led by Assistance Publique Hopitaux De Marseille · Updated on 2025-03-17
48
Participants Needed
2
Research Sites
116 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cluster headache is a primary headache. The chronic form of the disease is often difficult to treat. It is now considered a chronobiological disease. This chronobiological character is based on clinical, biological and radiological arguments. This study focuses on the use of light therapy in cluster headache. Light therapy has already been used in the treatment of other chronobiological diseases, such as seasonal depression, but also recently in the therapy of other primary headaches (such as migraine). Its aim is to re-adjust chronobiological rhythms, and it therefore seems worth testing in the chronic form of cluster headache. Light therapy is delivered to the patient using a consumer electronics device.The main objective is to evaluate the prophylactic efficacy of light therapy in patients with chronic cluster headache.
CONDITIONS
Official Title
Efficacy of Light Therapy in Treatment of Chronic Cluster Headache
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female, 18 years old or more
- Diagnosis of chronic cluster headache according to ICHD-3 criteria
- At least 24 cluster headache seizures during baseline
- Stable prophylactic treatment for at least 1 month with commitment not to change it during the study
- Affiliated with the French social security system
- Understands and speaks French correctly
- Provided free and informed written consent
You will not qualify if you...
- Contraindication to light therapy or use of photosensitizing treatment
- History of eye diseases such as cataract, macular degeneration, glaucoma, retinitis pigmentosa
- Working night shifts
- Other neurological, psychiatric, or developmental disorders incompatible with the study
- Current treatment of cluster headache with melatonin
- Pregnant or breastfeeding women, persons deprived of liberty by judicial decision, socially vulnerable persons, or adults unable to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hopital La Timone
Marseille, France, 13005
Actively Recruiting
2
Hôpital de Cimiez
Nice, France, 06000
Not Yet Recruiting
Research Team
A
Anne DONNET
CONTACT
S
Sophie Tardoski
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here